Celgene Corp. (CELG)

90.20
NASDAQ : Health Technology
Prev Close 90.91
Day Low/High 90.08 / 90.99
52 Wk Low/High 58.59 / 98.97
Avg Volume 4.59M
Exchange NASDAQ
Shares Outstanding 705.26M
Market Cap 64.12B
EPS 5.70
P/E Ratio 13.88
Div & Yield N.A. (N.A)
Oil Prices Keep Rising on OPEC Deal; Bluebird, Celgene T-Cell Therapy Sees Success

Oil Prices Keep Rising on OPEC Deal; Bluebird, Celgene T-Cell Therapy Sees Success

Oil prices continued their upward climb Thursday, buoyed by Wednesday's landmark OPEC agreement.

My Takeaways and Observations

The important messages today are the developing divergences.    The strength in energy stocks (reflecting a $3.88 a barrel rise in crude oil) masked the underlying weakness in the broader markets. Stated simply, these divergences in breadth, highs/l...

My Takeaways and Observations (2 p.m. Edition)

"Takeaways" is early today as I have to prepare for two company meetings tomorrow morning.   I am seeing signs of some exhaustion after the vigorous two-week advance in the markets -- especially in the "league-leading" Russell Index. The Russell wil...

My Takeaways and Observations (3:30 p.m. Edition)

It may be time to embrace the contrary.    First issue (!!): The Palm Beach Chronicles.   My weekly (brief) technical review of the markets -- cooling off ahead?    BTIG's Stockton is bullish and so, as I have expressed, are most others!   Campbell ...

The Good, the Bad and the Ugly (2:30 PM Edition)

"If you work for a living, why the hell do you kill yourself working?" -- Tuco the Ugly "The Good, the Bad and the Ugly" I did only a small amount of trading today (and added to short exposure), and there will be no "Takeaways" today (it's family ti...

Cramer: Trump Rally is a FANG + FANG Affair

Cramer: Trump Rally is a FANG + FANG Affair

Today high-growth tech and natural resources stocks are both going higher without sending much lower at all.

My Takeaways and Observations (2:30 p.m. Edition)

For now the run has been easy. But, from my perch, going forward it may not be as much fun, it wont be easy.    Changing leadership in a Trump world.    Trade of the Week -- shorted iShares Russell 2000 Index ETF at $131.50.    West Coast housing im...

Biotech Stocks May be Cheap But Large Scale M&A May Elude the Sector

Biotech Stocks May be Cheap But Large Scale M&A May Elude the Sector

Investors in biotech stocks appear to be happy with a Trump win and Mizuho's senior biotech analyst says companies in the sector could continue to climb in 2017.

Cramer: Why Are These Stocks Doing Well?

Cramer: Why Are These Stocks Doing Well?

Suspicious minds want to know.

My Takeaways and Observations (Early Edition)

The consideration of the contrary has been a theme all week. And here in "Don't Run With the Crowd: Embrace the Contrary."    Miami madness (of a real estate kind)    Mark Grant is scared by our currency's strength.    Danielle on scenarios.    Booc...

Celgene Rally Is No Flash in the Pan; More Gains to Come

Celgene Rally Is No Flash in the Pan; More Gains to Come

It looks like CELG could retest the highs around $140.

My Takeaways and Observations

At the end of the day!    Don't run with the crowd: Embrace contrary and second-level thinking instead.    Extreme policy uncertainty.    More Howard Marks.    Less Bill Miller.    My little sister!    Graf wrote a goodie.    The movie was in revers...

My Takeaways and Observations

"Today I am asking myself ... Did the FANG names just peak the way iShares NASDAQ Biotechnology Index ETF IBB did in 2015 and Energy Select Sector SPDR ETFXLE did in 2014? The S&P 500 Index kept rising, but those two groups were done!"  -- Kass Diar...

Midday Report: Stocks Higher As Wall Street Shrugs Off Trump's Presidential Election

Midday Report: Stocks Higher As Wall Street Shrugs Off Trump's Presidential Election

U.S. stocks rallied slightly in midday trading as energy, financials, and healthcare sectors saw green on Wednesday following the surprise election of Republican Donald Trump.

The Market Offers Some Opportunities but They're Disappearing Fast

The Market Offers Some Opportunities but They're Disappearing Fast

The market isn't buying that Trump is bad for business

Celgene Chart Has Surprising Strength

Celgene Chart Has Surprising Strength

Momentum is very good here and relative strength has improved greatly.

Rev's Forum: Trump Stunner Creates Huge Trading Opportunities

Rev's Forum: Trump Stunner Creates Huge Trading Opportunities

Our job now is to digest the news, shake off the emotions and find a way to benefit from it.

Celgene Is a High Quality Company Selling at a Discount

Celgene Is a High Quality Company Selling at a Discount

It has real earnings, not some artificial, buyback-supported junk.

My Takeaways and Observations

"Dougie, take what Mr. Market gives you." -- Grandma Koufax And I did, Grandma Koufax.   A consecutive nine-day market drop was snapped as we regained most that was lost in that period.   Today was a great day. (Boy, would I like to annualize the pe...

Cramer: Let's Look Beyond the Ballot Box

Cramer: Let's Look Beyond the Ballot Box

After the election passes we are going to talk about companies again -- and these have done well.

You Have to Be Willing to Buy Some Broken Charts

You Have to Be Willing to Buy Some Broken Charts

That's because the big issue is how to put capital to work.

Some Potential Positives Today

Some potential positives today: Strength in the Russell Index. Improving breadth. Improving Clinton odds by "538" and the London betting parlors. A great deal of pushback to my idea of a trading rally. Turnaround in large-cap biotech (Allergan , Cel...

Four Large Cap Stocks That Appear Ready to Rebound

Four Large Cap Stocks That Appear Ready to Rebound

Four Large Cap Stocks Ready to Rebound: Home Depot, Celgene, Charles Schwab and Allergan

Biotech Stocks Rise As Most Other Sectors Fall

Biotech Stocks Rise As Most Other Sectors Fall

The downdraft may reflect investors and traders view that Trump will win.

The Good, the Bad and the Ugly (2:30 PM Edition)

"It's not a joke, it's a rope, Tuco. Now I want you to get up there and put your head in that noose."  -- Blondie in "The Good, the Bad and the Ugly." I did very little today, save adding to my bank/financial shorts. I moved back to Market Neutral. ...

Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed

Take a Chill Pill: If Clinton Wins, Drug-Price Controls Aren't Guaranteed

Such unwarranted fears have depressed the sector, which could bounce back after Nov. 8.

Betting on a Biotech Rally

Betting on a Biotech Rally

Bargains abound in this beaten-down sector.

You Should Be Your Own Harshest Critic

You Should Be Your Own Harshest Critic

tk

2 Mistreated Small-Caps to Buy on Pullbacks

2 Mistreated Small-Caps to Buy on Pullbacks

Biotech Omeros and builder LGI Homes both seem substantially undervalued given their prospects.